ClinicalTrials.Veeva

Menu

Activation of Alternative Cellular Energy (ACE) Pathway in the Therapy of Herpes Virus Infections

I

Institute of Progressive Medicine

Status

Completed

Conditions

Herpes Simplex
Herpes Zoster

Study type

Observational

Funder types

Other

Identifiers

NCT00642785
071/081

Details and patient eligibility

About

The research question to be addressed is whether indirect phototherapy based activation of the body's alternative cellular energy (ACE) pathway will lead to expedited healing of active herpes simplex virus (HSV) and herpes zoster virus (HZV)skin lesions, and also possibly inhibit both latent HSV infections and residual HZV infections.

Enrollment

500 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of active, latent or residual HSV or HZV infection

Exclusion criteria

  • Unwilling or unable to provide Informed Consent

Trial design

500 participants in 4 patient groups

1
Description:
Patients with active oral or genital HSV skin lesions
2
Description:
Patients with a history of recurrent oral or genital HSV but without an active lesion at the time of treatment
3
Description:
Patients with active shingles/zoster
4
Description:
Patients with post herpetic neuralgia

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems